Mitogen- and stress-activated kinase 1 (MSK1), a downstream effector of p38 MAPK, modulates breast cancer dormancy by altering chromatin structure and reducing luminal differentiation gene expression (e.g., GATA3, FOXA1) (102). Here, RPS6KA5 is linked to breast carcinoma.